![](/img/cover-not-exists.png)
Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes
Lamos, Elizabeth M, Younk, Lisa M, Davis, Stephen NVolume:
23
Language:
english
Journal:
Expert Opinion on Investigational Drugs
DOI:
10.1517/13543784.2014.909407
Date:
June, 2014
File:
PDF, 308 KB
english, 2014